Hemostasis
Leadership
Mission and Goals
- To keep up to date with current guidelines regarding treating cancer patients with bleeding and clotting problems related to their disease.
- To evaluate current guidelines for their merits and deficiencies in providing adequate treatment to cancer patients with coagulation problems.
- To promote multinational and multidisciplinary cooperative networks among those involved in the care of cancer patients with thrombotic and bleeding complications; including physicians, nurses, pharmacists, psychologists, and other professionals involved in patient education.
- To focus on anticoagulation treatment and quality of life in cancer patients in different settings during the cancer journey: VTE prevention and management; outpatient and inpatient settings; VTE and bleeding complications in patients receiving active cancer-specific treatments as well as those receiving palliative care.
How to Join
To join a study group, you must be a MASCC member. Members can belong to up to three study groups.
